PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.
PMCB Stock Jumps 25% After Company Sells Stake In Femasys
PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.